The ASCO Central and Eastern Europe Regional Council has identified a need for training in molecular tumor boards (MTBs). This 6-session virtual Project ECHO program is designed to increase knowledge of MTBs, create a network of like-minded professionals in the Region to share experiences, and to contribute to improved access of MTBs. The interactive program consists of six 1.5-hour monthly sessions that include didactics from recognized experts in the field and multidisciplinary case-based discussions.
Schedule: Every other Wednesday evening in the Central and Eastern European Region.
Target Audience:
Multidisciplinary participation from Central and Eastern European countries who currently, or wish to, participate in molecular tumor boards within their institutions. These include: oncologists, hematologist, molecular pathologists, cancer geneticists, and cancer genetic counselors.
Program Learning Objectives:
- Understand the Role and Importance of Molecular Tumor Boards
- Identify and Overcome Barriers to Molecular Testing and Molecular Tumor Board Implementation
- Learn how to Integrate Genomic Data into Clinical Practice
- Participate in case-based learning and mock Molecular Tumor Board discussions
Sessions
January 21: Introduction to Molecular Tumor Boards and Their Role in Precision Oncology
6-7:30pm CET; 7-8:30pm EET; 8-9:30pm Turkey; 12-1:30pm ET; 11am- 12:30pm CT
February 4: Molecular Diagnostics, NGS Testing and Genomic Alterations in Oncology
6-7:30pm CET; 7-8:30pm EET; 8-9:30pm Turkey; 12-1:30pm ET; 11am- 12:30pm CT
February 18: Implementing MTB – Workflow, Consensus to Decision-Making, Best Practices
6-7:30pm CET; 7-8:30pm EET; 8-9:30pm Turkey; 12-1:30pm ET; 11am- 12:30pm CT
March 4: Case-Based Learning – Mock MTB and Advanced Clinical Decision-Making
6-7:30pm CET; 7-8:30pm EET; 8-9:30pm Turkey; 12-1:30pm ET; 11am- 12:30pm CT
March 18: Advanced Case-Based Learning – Complex Cases and Collaborative Decision-Making
6-7:30pm CET; 7-8:30pm EET; 8-9:30pm Turkey; 1-2:30pm ET; 12-1:30pm CT
April 1: Addressing Barriers to Genomic Testing and MTB Implementation in Eastern Europe
7-8:30pm CET; 8-9:30pm Turkey & EET; 1-2:30pm ET; 12-1:30pm CT
